Article
Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.
Antimicrobial agents and chemotherapy - 1 Sept 2015
Ramirez-Busby Sarah M, Valafar Faramarz
Abstract excerpt
Pyrazinamide (PZA) is an important first-line drug in the treatment of tuberculosis (TB) and of significant interest to the HIV-infected community due to the prevalence of TB-HIV coinfection in some regions of the world. The mechanism of resistance to PZA is unlike that of any other anti-TB drug....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
